Camlin Fine Sciences Limited
Camlin Fine Sciences Limited, together with its subsidiaries, research, develops, manufactures, and markets specialty chemicals, ingredients, and additive blend products in India and internationally. The company offers shelf-life solutions, which include basic ingredients, such as tert-butylhydroquinone (TBHQ), Butylated Hydroxyanisole (BHA), Butylated Hydroxytoluene (BHT), and Ascorbyl Palmitate… Read more
Camlin Fine Sciences Limited (CAMLINFINE) - Total Assets
Latest total assets as of September 2025: ₹20.37 Billion INR
Based on the latest financial reports, Camlin Fine Sciences Limited (CAMLINFINE) holds total assets worth ₹20.37 Billion INR as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Camlin Fine Sciences Limited - Total Assets Trend (2007–2025)
This chart illustrates how Camlin Fine Sciences Limited’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Camlin Fine Sciences Limited - Asset Composition Analysis
Current Asset Composition (March 2025)
Camlin Fine Sciences Limited's total assets of ₹20.37 Billion consist of 58.5% current assets and 41.5% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₹358.16 Million | 5.1% |
| Accounts Receivable | ₹3.38 Billion | 16.7% |
| Inventory | ₹5.27 Billion | 26.0% |
| Property, Plant & Equipment | ₹6.54 Billion | 32.3% |
| Intangible Assets | ₹102.26 Million | 0.5% |
| Goodwill | ₹474.67 Million | 2.4% |
Asset Composition Trend (2007–2025)
This chart illustrates how Camlin Fine Sciences Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Camlin Fine Sciences Limited's current assets represent 58.5% of total assets in 2025, an increase from 40.8% in 2007.
- Cash Position: Cash and equivalents constituted 5.1% of total assets in 2025, up from 0.7% in 2007.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, an increase from 0.0% in 2007.
- Asset Diversification: The largest asset category is property, plant & equipment at 32.3% of total assets.
Camlin Fine Sciences Limited Competitors by Total Assets
Key competitors of Camlin Fine Sciences Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Akzo Nobel N.V
OTCQX:AKZOF
|
USA | $13.95 Billion |
|
YeSUN Tech Co.Ltd.
KQ:250930
|
Korea | ₩51.65 Billion |
|
Hangzhou Flariant Co Ltd
SHG:605566
|
China | CN¥2.55 Billion |
|
Samhwa Paint
KO:000390
|
Korea | ₩617.09 Billion |
|
DL Holdings CO. LTD.
KO:000210
|
Korea | ₩12.05 Trillion |
|
Norooholdings
KO:000320
|
Korea | ₩1.26 Trillion |
|
Noroo Holdings Co Ltd
KO:000325
|
Korea | ₩1.26 Trillion |
|
Chongqing Sanxia Paints Co Ltd
SHE:000565
|
China | CN¥1.65 Billion |
Camlin Fine Sciences Limited - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Camlin Fine Sciences Limited generates 0.82x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Camlin Fine Sciences Limited is currently not profitable relative to its asset base.
Camlin Fine Sciences Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.36 | 1.20 | 1.47 |
| Quick Ratio | 0.74 | 0.61 | 0.85 |
| Cash Ratio | 0.14 | 0.11 | 0.00 |
| Working Capital | ₹3.11 Billion | ₹ 1.71 Billion | ₹ 2.39 Billion |
Camlin Fine Sciences Limited - Advanced Valuation Insights
This section examines the relationship between Camlin Fine Sciences Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.13 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | 3.7% |
| Total Assets | ₹20.24 Billion |
| Market Capitalization | $130.29 Million USD |
Valuation Analysis
Below Book Valuation: The market values Camlin Fine Sciences Limited's assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Camlin Fine Sciences Limited's assets grew by 3.7% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Camlin Fine Sciences Limited (2007–2025)
The table below shows the annual total assets of Camlin Fine Sciences Limited from 2007 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | ₹20.24 Billion | +3.69% |
| 2024-03-31 | ₹19.52 Billion | -5.26% |
| 2023-03-31 | ₹20.60 Billion | +14.44% |
| 2022-03-31 | ₹18.00 Billion | +21.50% |
| 2021-03-31 | ₹14.82 Billion | +20.06% |
| 2020-03-31 | ₹12.34 Billion | +13.55% |
| 2019-03-31 | ₹10.87 Billion | +6.92% |
| 2018-03-31 | ₹10.16 Billion | +51.15% |
| 2017-03-31 | ₹6.73 Billion | +39.32% |
| 2016-03-31 | ₹4.83 Billion | +12.34% |
| 2015-03-31 | ₹4.30 Billion | +15.31% |
| 2014-03-31 | ₹3.73 Billion | +0.85% |
| 2013-03-31 | ₹3.69 Billion | +29.37% |
| 2012-03-31 | ₹2.86 Billion | +54.76% |
| 2011-03-31 | ₹1.85 Billion | +53.91% |
| 2010-03-31 | ₹1.20 Billion | +28.45% |
| 2009-03-31 | ₹933.46 Million | +38.53% |
| 2008-03-31 | ₹673.81 Million | +16.66% |
| 2007-03-31 | ₹577.58 Million | -- |